Industries Market Research Reports

Subscribe to RSS Feed
  1. 15 Oct 2024  |  Global  |  Technology Research

    Emerging Non-opioid Treatments for Pain Management

    Advances in Non-opioid Therapies for Neuropathic, Migraine, and Cancer Pain Management Unlock New Growth Opportunities

    The analysis explores cutting-edge advancements in non-opioid medications by delving into their mechanisms of action at a molecular scale, scrutinizing results from current clinical research initiatives, and appraising preparedness for and plausibility of regulatory approval. The considerations aim to highlight how these treatments may offer viable...

    $4,950.00
  2. 25 Jul 2024  |  Global  |  Technology Research

    Engineered Antibody Therapeutics for Cancer

    Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies

    This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

    $4,950.00
  3. 24 Jul 2024  |  Global  |  Technology Research

    Menopause Care Management Technology Growth Opportunities, 2024 2029

    Growing competitive intensity fuels future growth potential in menopause care management

    As the global population ages, more attention should be paid to the needs of individuals aged 45 to 55, particularly women in the perimenopausal and menopausal stages. Women aged 45 and above are at a crucial stage in terms of professional and personal responsibilities; however, they are challenged by menopausal symptoms, such as hot flashes, sleep...

    $4,950.00
  4. 25 Jun 2024  |  Global  |  Market Research

    Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029

    Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential

    By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

    $4,950.00
  5. 14 Jun 2024  |  Global  |  Market Research

    Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028

    GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth

    Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

    $4,950.00
  6. 13 Nov 2018  |  Global  |  Technology Research

    Artificial Intelligence Revolutionizing the Pharmaceutical Industry

    Optimal Synergy Between Leading-edge Computational Science and Therapeutics Development

    The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

    $4,950.00

    Special Price $3,712.50 save 25 %

  7. 30 Oct 2018  |  Africa  |  Market Research

    Healthcare Regulatory Environment in Kenya, Tanzania, and Ethiopia, 2018

    Unlocking Investment Potential and Improving Healthcare Delivery and Access through Policy Advancement

    The East African region boasts of a number of emerging leaders within Sub-Saharan Africa in terms of overall development and growth. On one hand, the region has one of the highest burdens of disease in the world, such as HIV, malaria, and tuberculosis. On the other hand, there has been a growing trend of non-communicable diseases, such as cancers a...

    $1,500.00

    Special Price $1,125.00 save 25 %

  8. 24 Oct 2018  |  North America  |  Market Research

    Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

    A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

    The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

    $4,950.00

    Special Price $3,712.50 save 25 %

  9. 04 Sep 2018  |  North America  |  Market Research

    Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

    Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

    The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally ...

    $3,000.00

    Special Price $2,250.00 save 25 %

  10. 29 Jun 2018  |  Global  |  Technology Research

    Novel Therapies for Rare and Genetic Diseases

    Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy

    Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

    $4,950.00

    Special Price $3,712.50 save 25 %